Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03678441 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Nov 5, 2025, no change to tracked fieldsv11-v12
  2. Primary and study completion dates: Apr 30, 2025 to Apr 30, 2027v10
  3. Re-verified, no change to tracked fieldsv9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v8
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: May 31, 2023 to Apr 30, 2025v6
  2. Primary and study completion dates: Dec 31, 2022 to May 31, 2023v5
  3. Primary and study completion dates: Dec 31, 2021 to Dec 31, 2022v4
  4. Primary completion date: Dec 31, 2019 to Dec 31, 2021
    • Study completion date: Dec 31, 2020 to Dec 31, 2021
    • Site contact updated
    v3
  5. Study completion date: Dec 31, 2019 to Dec 31, 2020
    • Study description expanded, about 3 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.
Trial Details
NCT Number NCT03678441
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Liver and Intrahepatic Bile Duct Disorder
Related terms Digestive System Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov